Kiora Pharmaceuticals, Inc.

This study is testing whether repeated injections of an experimental drug called KIO-301 into the eye is safe and can help improve vision in people with late-stage retinitis pigmentosa, a genetic disease that causes severe vision loss. It will involve about 36 adults who have ver…

This study is testing an experimental eye injection called KIO-104 for people with macular edema, a condition where fluid builds up in the central part of the retina and can blur vision. Researchers are enrolling 28 adults to receive injections every 2 or 4 weeks to see if the tr…

This early-stage study is testing the safety and tolerability of an experimental drug called KIO-301, which is injected directly into the eye. It aims to help adults aged 18-80 with severe vision loss from genetic eye diseases like retinitis pigmentosa and choroideremia. The main…